METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITION
First Claim
Patent Images
1. A CRISPR/Cas nuclease comprising a single guide RNA that binds to a target site in an enhancer region of a BCL11 a gene, wherein the nuclease cleaves and inactivates the BCL11a gene.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods and compositions for comprising single guide RNAs targeted to an endogenous gene for genetic alteration of cells are provided.
16 Citations
17 Claims
- 1. A CRISPR/Cas nuclease comprising a single guide RNA that binds to a target site in an enhancer region of a BCL11 a gene, wherein the nuclease cleaves and inactivates the BCL11a gene.
Specification